Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

1.2K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.2K
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

628
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
628
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

633
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
633
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

5.4K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
5.4K
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

1.9K
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
1.9K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

1.0K
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postpartum Plasma-Derived Exosomes Confer Mitochondrial Stabilization and Neuroprotection against Ischemic Stroke.

Research square·2026
Same author

Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 update.

Gynecologic oncology·2026
Same author

Association Between Delivery Mode and Postpartum Psychiatric Conditions.

Obstetrics and gynecology·2026
Same author

Prospective clinical study for assessing real-time objective pain using a signal processing algorithm in conjunction with wearable forehead sensors.

Journal of clinical anesthesia·2026
Same author

Biopsychosocial predictors of chronic pain after caesarean delivery: a prospective cohort evaluation of the SPACE (Sleep, Pain, Affect, Cognition, Energy)-Postpartum framework.

BJA open·2026
Same author

Cesarean Anesthesia Type and Neonatal Outcomes: Comment.

Anesthesiology·2026

Related Experiment Video

Updated: Mar 21, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

12.0K

Amniotic fluid embolism: update and review.

Pervez Sultan1, Katherine Seligman, Brendan Carvalho

  • 1aUniversity College London Hospital, London, UKbDepartment of Anesthesia, Stanford University School of Medicine, California, USA.

Current Opinion in Anaesthesiology
|May 7, 2016
PubMed
Summary
This summary is machine-generated.

Amniotic fluid embolism (AFE) is a rare but severe obstetric emergency. Early intervention focusing on cardiopulmonary support and coagulopathy management is crucial for survival, with biomarkers and immunomodulation offering future treatment hope.

More Related Videos

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

11.9K
A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

945

Related Experiment Videos

Last Updated: Mar 21, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

12.0K
Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

11.9K
A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

945

Area of Science:

  • Obstetrics and Gynecology
  • Immunology
  • Critical Care Medicine

Background:

  • Amniotic fluid embolism (AFE) is a life-threatening obstetric complication with variable incidence and mortality rates globally.
  • The pathogenesis is linked to the entry of fetal antigens into maternal circulation, triggering immunologic and inflammatory responses.
  • Current understanding involves mast cell degranulation and complement activation in the anaphylactoid or systemic inflammatory response syndrome.

Purpose of the Study:

  • To review the current understanding of amniotic fluid embolism (AFE).
  • To discuss AFE pathogenesis, diagnostic advancements, and therapeutic strategies.
  • To explore potential future interventions for AFE.

Main Methods:

  • Literature review of current understanding of amniotic fluid embolism (AFE).
  • Analysis of pathogenesis, diagnostic tests, and treatment strategies.
  • Evaluation of emerging biomarkers and immunomodulatory therapies.

Main Results:

  • AFE incidence and mortality vary due to diagnostic heterogeneity.
  • Immunologic mechanisms, including mast cell degranulation and complement activation, are implicated in AFE.
  • Supportive care for cardiovascular, pulmonary, and coagulation derangements is primary treatment.
  • Prompt management of coagulopathy with blood products and antifibrinolytics is essential.
  • Recombinant factor VIIa is not recommended; C1 esterase inhibitors show potential.

Conclusions:

  • AFE necessitates early, aggressive intervention including cardiopulmonary resuscitation and hemorrhage/coagulopathy management.
  • Biomarkers show promise for improving AFE diagnosis.
  • Immunomodulation represents a potential future therapeutic avenue for AFE.